USANA Health Sciences (NYSE: USNA) reported Q3 EPS of $1.92, $0.16 better than the analyst estimate of $1.76. Revenue for the quarter came in at $233.3 million versus the consensus estimate of $224.53 million.

USANA Health Sciences sees FY2015 EPS of $7.25-$7.35, versus prior guidance of $6.90-$7.20 and the consensus of $7.16. USANA Health Sciences sees FY2015 revenue of $915-920 million, versus the consensus of $916.8 million.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.